Trade Associations
Here's a look at documents from national and international trade associations
Featured Stories
ACP says increased oversight of private equity in health care is needed to protect patients and the physician workforce
PHILADELPHIA, Pennsylvania, May 25 [Category: Medical] -- The American College of Physicians posted the following news release:
* * *
ACP says increased oversight of private equity in health care is needed to protect patients and the physician workforce
*
PHILADELPHIA, May 25, 2026-Private equity investment in health care requires increased regulatory oversight and policies to better protect patients and physicians from the adverse impact of growing corporate interests, says the American College of Physicians (ACP). In a new paper, " Regulatory Framework for Private Equity and Corporatization
... Show Full Article
PHILADELPHIA, Pennsylvania, May 25 [Category: Medical] -- The American College of Physicians posted the following news release:
* * *
ACP says increased oversight of private equity in health care is needed to protect patients and the physician workforce
*
PHILADELPHIA, May 25, 2026-Private equity investment in health care requires increased regulatory oversight and policies to better protect patients and physicians from the adverse impact of growing corporate interests, says the American College of Physicians (ACP). In a new paper, " Regulatory Framework for Private Equity and Corporatizationin Health Care: A Position Paper from the American College of Physicians," published today in Annals of Internal Medicine, ACP examines the impact of private equity investment on clinical autonomy, health care costs, quality, access, equity, and innovation, and makes recommendations to help ensure that patient-centered care is protected.
In recent years, private equity investments in health care have increased substantially, growing from $41.5 billion in 2010 to $119.9 billion in 2019, with the trend expected to continue in the upcoming years. These investments have increasingly focused on primary care and multispecialty practices, driven in part by financial pressures on physician practices. Physicians have been leaving private practice due to high costs, inadequate reimbursement rates, and burnout. Instead of physicians funding and expanding their practices, investment patterns have shifted toward institutional investments by large firms that may not have expertise in health care delivery. The trend is concerning because some evidence associates private equity investment in health care with higher costs and, in certain settings, adverse effects on care delivery and patient outcomes.
"Given the increasing role that private equity plays in the health care system, we need to know more about its impact," said Jan K. Carney, MD, MPH, MACP, president, ACP. "There is a fundamental difference between the long-term nature of health care delivery goals and the need for short-term returns on private equity investments. Those competing incentives underscore the need for strong policies to ensure that patient-centered care remains the priority."
In the new paper, ACP outlines a series of recommendations to better regulate private equity investments. Policymakers should establish safeguards to ensure that physicians retain control of patient care and discourage prioritizing profits over patients. ACP calls for greater transparency in health care investments, including requiring private equity firms to disclose information on patient experiences and outcomes. There should be regulatory oversight of private equity activities to prevent practices such as inappropriate self-referrals, excessive reliance on non-physician clinicians without appropriate physician involvement, or consolidation that reduces competition. ACP recommends increased scrutiny of practices that disproportionately affect vulnerable and underserved communities. Federal officials should strengthen enforcement and impose penalties on firms that violate the False Claims Act or engage in fraud or kickbacks.
ACP also recommends enhanced oversight of private equity entities that receive funding from federal payment programs, like Medicare and Medicaid. ACP calls for further examination of the impact of private equity and consolidation in the health care sector, including research into how these investments affect enrollment, spending, clinical outcomes, and health equity in Medicare, Medicare Advantage, and other federal health programs. Finally, ACP calls for additional research into how private equity affects the physician workforce and practice composition, including whether there are circumstances in which private equity investment could help expand access in rural communities or support investment in value-based care models.
About the American College of Physicians
The American College of Physicians is the largest medical specialty organization in the United States with members in more than 172 countries worldwide. ACP membership includes 163,000 internal medicine physicians, related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on X, Facebook, Instagram, Threads and LinkedIn, and subscribe to our new RSS feed.
Contact : Jacquelyn Blaser, Jblaser@acponline.org, 202-261-4572
***
Original text here: https://www.acponline.org/acp-newsroom/acp-says-increased-oversight-of-private-equity-in-health-care-is-needed-to-protect-patients-and-the
TMA Signs Letter in Support of Provider Reimbursement Stability Act
NASHVILLE, Tennessee, May 23 -- The Tennessee Medical Association issued the following news:
* * *
TMA Signs Letter in Support of Provider Reimbursement Stability Act
By Jonathan Kirkland
The Tennessee Medical Association (TMA) joined healthcare organizations across the nation in signing a letter in support of H.R. 8163, the "Provider Reimbursement Stability Act. The legislation makes progress towards an improved Medicare physician payment system that benefits not only physicians, but critcal access to patient care.
The letter, delivered to Rep. Greg Murphy, MD and Rep. Tom Suozzi, gives
... Show Full Article
NASHVILLE, Tennessee, May 23 -- The Tennessee Medical Association issued the following news:
* * *
TMA Signs Letter in Support of Provider Reimbursement Stability Act
By Jonathan Kirkland
The Tennessee Medical Association (TMA) joined healthcare organizations across the nation in signing a letter in support of H.R. 8163, the "Provider Reimbursement Stability Act. The legislation makes progress towards an improved Medicare physician payment system that benefits not only physicians, but critcal access to patient care.
The letter, delivered to Rep. Greg Murphy, MD and Rep. Tom Suozzi, givesbackground information on the erosion of Medicare physician payment over the past several decades. Organizations who signed on collectively emphasized the improtant step forward this legislation represents.
"We strongly support the Provider Reimbursement Stability Act and urge its prompt passage," reads the letter. "This legislation should be understood as a part of a broader reform agenda, and we continue to call for an annual inflationary update to Medicare physician payments tied to the MEI. Together, these reforms would go far toward establishing a Medicare physician payment system that is adequate, stable, predictable, and reflective of the actual costs of delivering care."
On Thursday, May 21, H.R. 8163 passed through the House Ways and Means Committee. TMA will continue to monitor and support this and any legislation that improves Medicare payment processes.
* * *
INFODOC: https://tennesseemedicalassociation.growthzoneapp.com/ap/CloudFile/Download/pBNy2Oop
* * *
Original text here: https://members.tnmed.org/news/Details/tma-signs-letter-in-support-of-provider-reimbursement-stability-act-333868
[Category: Medical]
Southern Shrimp Alliance: Destruction of Hazardous Imports Act Advances to Floor From House Energy and Commerce Committee
NEW PORT RICHEY, Florida, May 23 -- The Southern Shrimp Alliance issued the following news release:
* * *
Destruction of Hazardous Imports Act Advances to Floor from House Energy and Commerce Committee
Legislation Authorizing the FDA to Order the Destruction of Imports that Pose Significant Public Health Risks Takes Another Major Step Forward.
*
Roughly one week after the Health Subcommittee of the House Committee on Energy and Commerce met for a markup that included the Destruction of Hazardous Imports Act (H.R. 2715), the full House Committee on Energy and Commerce met yesterday for a markup
... Show Full Article
NEW PORT RICHEY, Florida, May 23 -- The Southern Shrimp Alliance issued the following news release:
* * *
Destruction of Hazardous Imports Act Advances to Floor from House Energy and Commerce Committee
Legislation Authorizing the FDA to Order the Destruction of Imports that Pose Significant Public Health Risks Takes Another Major Step Forward.
*
Roughly one week after the Health Subcommittee of the House Committee on Energy and Commerce met for a markup that included the Destruction of Hazardous Imports Act (H.R. 2715), the full House Committee on Energy and Commerce met yesterday for a markupin including the legislation. Along with several other bills, the Energy and Commerce Committee advanced the Destruction of Hazardous Imports Act out of Committee to now be considered by the full House of Representatives.
The legislation, as amended, was reported favorably out of the Committee with a strong bipartisan roll call vote of 43 yeas to 0 nays.
At the full Committee markup, Congressman Troy Carter (D-LA) - one of the original sponsors of the bipartisan bill along with Congressman Clay Higgins (R-LA) - offered a further amendment to the bill providing greater specificity as to the procedures through which the U.S. Food and Drug Administration (FDA) will promulgate regulations to implement this new authority to order destruction of unsafe merchandise.
In comments introducing the Destruction of Hazardous Imports Act to the full Committee, Representative Carter emphasized how existing law allowed unscrupulous exporters, particularly from China, to get contaminated seafood products, dangerous vape and e-cigarettes, and counterfeit drugs, like GLP-1s, into the United States by evading the U.S. Food and Drug Administration's (FDA) controls through port shopping. Congressman Carter noted that providing the FDA with this authority has been a priority for both the Biden and Trump Administrations and that the legislation was supported by a broad coalition of organizations, including the Southern Shrimp Alliance and the Louisiana Farm Bureau.
Why this bill is needed
Under current law, exporters can ship contaminated merchandise to the United States, withdraw the merchandise if flagged by the FDA, and try to bring it in later at a different port. This practice, known as "port shopping," exploits the FDA's weak inspection system and allows contaminated foods--particularly seafood--to reach American plates even after federal regulators have already rejected them.
The problem extends beyond food. At the Subcommittee's hearing on the bill in March, experts testified as to the need to close a loophole in existing law. Congressman Carter noted a rise in the exportation of dangerous vape devices and counterfeit drugs to the United States, often with no consequences for the exporters. The Destruction of Hazardous Imports Act closes this loophole and disincentivizes foreign companies from shipping dangerous merchandise to the United States in the first instance.
Congressman Carter's comments emphasized the widespread support for the bill. He noted that obtaining the authority to order the destruction of goods that pose a significant public health risk has been an objective of the FDA under both the Biden and Trump Administrations. He also underscored that the legislation was supported by a broad group of industries and public advocacy groups, including the Southern Shrimp Alliance, the Louisiana Farm Bureau Federation, the Partnership for Safe Medicines, the National Association of State Controlled Substances Authorities, and the National Consumers League.
Shrimp Industry Response to the Energy and Commerce Committee's Markup
The Southern Shrimp Alliance (SSA) is grateful to the members of the House Committee on Energy and Commerce for prioritizing a bill that will protect American consumers and level the playing field for American seafood producers.
"Once again, the U.S. shrimp industry bears fortunate witness to the effectiveness of the bipartisan leadership of Congressman Troy Carter and Congressman Clay Higgins to eliminate a long-standing complaint of American shrimpers," said Blake Price, director of the Southern Shrimp Alliance."Any shrimp, seafood, or other FDA-regulated product that poses a significant public health risk to Americans must be kept out of our market. While the job is not yet done, we are proud to have been able to work with a large coalition of organizations, the FDA, and members of Congress to bring forward a workable, common sense legislative solution to a universally-recognized problem."
Closing the Port Shopping Loophole
The FDA itself has long recognized the dangers presented by this gap in existing law. Beginning in Fiscal Year 2023, the FDA requested authority to require the destruction of imported products that pose a significant public health risk. The FDA repeated this request in Fiscal Year 2024 and in Fiscal Year 2025. In its Fiscal Year 2026 Legislative Priorities, the federal agency revised its explanation regarding the need for this authority to provide greater detail regarding the nature of its concerns, particularly with respect to contaminated seafood:
"The Agency has observed importers exporting or attempting to re-import commercial- sized shipments that pose a significant public health concern including food contaminated with Salmonella, Listeria and carcinogenic unapproved animal drugs; human drugs such as hand sanitizer contaminated with methanol; and misbranded or adulterated devices such as contact lenses, COVID-19 test kits, and personal protective equipment. In May 2023, a high-volume importer/wholesaler pled guilty to attempting to re-import 2100 cartons of frozen eels from China that were refused by FDA because testing confirmed contamination with a carcinogenic unapproved animal drug. FDA believes this new authority would prevent reimportation of refused products and would deter importers from seeking to import products they know or have reason to believe would pose a significant public health risk and could be ordered destroyed."
Most recently, the FDA has again renewed its request for this legislative authority in its Fiscal Year 2027 Budget Justification. The problem extends beyond seafood. During a recent hearing before the Health Subcommittee of the House Committee on Energy and Commerce about the Destruction of Hazardous Imports Act, Dr. Nabarun Dasgupta, Senior Scientist and Gillings Innovation Fellow at the University of North Carolina, Chapel Hill, testified that port shopping is "a really common thing." He offered the example of muffins sold at a nationwide coffee shop chain that were found to contain plastic and refused entry, only to successfully enter the United States through another port and end up on the chain store's shelves.
Strong Bipartisan Support
The Destruction of Hazardous Imports Act was introduced in the House by Representatives Troy Carter (D-LA) and Clay Higgins (R-LA) and has attracted broad bipartisan support.
Currently, there are another fourteen bipartisan co-sponsors in the House of Representatives for H.R. 2715 from eight different states, including:
* Congressman Gus Bilirakis (R-FL)
* Congressman Don Davis (D-NC)
* Congresswoman Rosa DeLauro (D-CT)
* Congressman Mike Ezell (R-MS)
* Congressman Cleo Fields (D-LA)
* Congressman Mike Haridopolos (R-FL)
* Congresswoman Jennifer Kiggans (R-VA)
* Congresswoman Julia Letlow (R-LA)
* Congresswoman Nancy Mace (R-SC)
* Congressman Gregory Murphy (R-NC)
* Congressman Troy Nehls (R-TX)
* Congressman John Rutherford (R-FL)
* Congressman Gregory Steube (R-FL)
* Congressman Randy Weber (R-TX)
The Senate version of the bill (S. 3213), introduced by Senator Rick Scott (R-FL), has been co-sponsored by Senator Cindy Hyde-Smith (R-MS) and Senator John Kennedy (R-LA).
Strong Public Support
As noted at the Committee markup by Representative Troy Carter, a large coalition of organizations have coalesced around the bill, spanning from federal regulators, consumer safety advocates, and the domestic seafood industry.
In February 2026, the Southern Shrimp Alliance led a coalition letter signed by sixteen American seafood-producing organizations to the House Energy and Commerce Committee and the Senate Committee on Health, Education, Labor, and Pensions, urging passage of the Destruction of Hazardous Imports Act.
The signatories included:
* Alaska Longline Fishermen's Association
* Apostleship of the Sea of the United States of America
* Chesapeake Bay Seafood Industries Association
* East Coast Shellfish Growers Association
* Gulf of America Reef Fish Shareholders' Alliance
* Hawaii Longline Association
* Louisiana Crawfish Processors Alliance
* Louisiana Farm Bureau Crawfish Advisory Committee
* Maine Coast Fishermen's Association
* North American Marine Alliance
* North Carolina Fisheries Association
* Oregon Trawl Commission
* Port Arthur Area Shrimpers Association
* Southeastern Fisheries Association
* Southern Shrimp Alliance
* Texas Shrimp Association
In March 2026, the Safe Food Coalition sent their own coalition letter signed by eight public health and safety advocacy organizations to the House Energy and Commerce Committee and the Senate Committee on Health, Education, Labor, and Pensions, also urging passage of the Destruction of Hazardous Imports Act.
The signatories of the Safe Food Coalition letter included:
* Center for Science in the Public Interest
* Consumer Federation of America
* Consumer Reports
* Farm Forward
* Food & Water Watch
* Government Accountability Project
* Institute for Food Safety &Nutrition Security
* Stop Foodborne Illness
Before that, a September 4, 2025 coalition letter from organizations "committed to protecting patient safety and securing the integrity of the United States supply chain" also directed at the House Energy and Commerce Committee and the Senate Committee on Health, Education, Labor, and Pensions, expressed strong support for the FDA's request for authority to order the destruction of dangerous imports, explaining that under current law, the FDA's process "sometimes results in [dangerous products] return to the rogue manufacturers, allowing these rogue manufacturers to port shop.
After this return, the rogue manufacturers simply reship them back to the United States, again aiming to breach our pharmaceutical border security and harm American patients."
The nine signatories of the September 4, 2025 letter included:
* Alliance for Safe Online Pharmacies (ASOP)
* ECRI
* Institute for Safe Medicine Practices
* The International AntiCounterfeiting Coalition
* National Association of Drug Diversion Investigators
* National Association of State Controlled Substances Authorities
* National Consumers League
* The Partnership for Safe Medicines
* Rx-360
What the Markup Means
A committee markup is the formal process by which a congressional committee considers, amends, and votes on legislation before sending it to the full chamber for a floor vote. The House Committee on Energy and Commerce's actions on Thursday mark another important milestone on the long path for legislation to become law and the legislation is now eligible for consideration on the House floor.
* * *
Original text here: https://shrimpalliance.com/destruction-of-hazardous-imports-act-advances-to-floor-from-house-energy-and-commerce-committee/
[Category: Food/Beverage]
American Supply Association: Federal Housing Reform Bill Targets Homebuilding Growth and Construction Supply Shortages
ITASCA, Illinois, May 23 -- The American Supply Association issued the following commentary by Director of Communications Natalie Forster:
* * *
Federal Housing Reform Bill Targets Homebuilding Growth and Construction Supply Shortages
This week, the U.S. House of Representatives passed sweeping bipartisan housing legislation that could carry significant implications for the residential and multifamily construction markets. The legislation, known as the 21st Century ROAD to Housing Act, is designed to address housing affordability by accelerating homebuilding, reducing regulatory barriers, expanding
... Show Full Article
ITASCA, Illinois, May 23 -- The American Supply Association issued the following commentary by Director of Communications Natalie Forster:
* * *
Federal Housing Reform Bill Targets Homebuilding Growth and Construction Supply Shortages
This week, the U.S. House of Representatives passed sweeping bipartisan housing legislation that could carry significant implications for the residential and multifamily construction markets. The legislation, known as the 21st Century ROAD to Housing Act, is designed to address housing affordability by accelerating homebuilding, reducing regulatory barriers, expandingmanufactured housing opportunities, and limiting certain institutional investor activity in the single-family housing market.
It appears that policymakers are increasingly focused on boosting housing supply, as the bill passed the House in a 396-13 bipartisan vote and is considered one of the most significant federal housing packages in decades. Among its core goals are streamlining permitting and environmental reviews, encouraging zoning modernization, reducing barriers to manufactured housing development, and lowering construction costs that have slowed housing starts nationwide.
Industry analysts have increasingly pointed to supply shortages, not just interest rates, as one of the primary drivers of the nation's affordability challenges. The Bipartisan Policy Center noted that the legislation combines multiple housing reform efforts aimed at increasing supply and modernizing housing programs.
One area that may be particularly relevant for distributors is the legislation's support for manufactured and factory-built housing. The bill includes provisions intended to reduce regulatory friction surrounding manufactured housing construction and development. Manufactured housing continues to gain traction as builders and developers search for faster, lower-cost construction methods amid persistent labor shortages and elevated project costs. Factory-built housing can create new opportunities for distributors supplying modular construction channels, particularly in fast-growth Sun Belt and suburban markets.
The legislation also attempts to address growing concerns around institutional investors purchasing large numbers of single-family homes. Earlier Senate language proposed aggressive restrictions on institutional ownership, though the House version softened several provisions after pushback from builders and housing groups.
While those investor-focused provisions have generated debate, many housing organizations have largely supported the bill's broader effort to reduce barriers to construction and increase housing inventory. The National Low Income Housing Coalition described the legislation as containing "common sense reforms" aimed at building housing more efficiently and lowering construction costs.
Even with the legislation advancing, elevated interest rates, labor shortages, land costs, and ongoing construction workforce constraints continue to pressure builders and developers across many markets. Those same issues have also impacted project timelines, inventory planning and demand visibility for distributors throughout the PHCP-PVF channel.
The overwhelming bipartisan support behind the legislation reflects recognition in Washington that housing supply has become both an economic and political priority.
* * *
By Natalie Forster
* * *
Original text here: https://www.asa.net/News/News/federal-housing-reform-bill-targets-homebuilding-growth-and-construction-supply-shortages
[Category: Industrial Materials]
American Dental Association: Court of Appeals Rules EPA Case 'Commandeered' by Lower Court
CHICAGO, Illinois, May 23 -- The American Dental Association issued the following news release:
* * *
Court of Appeals Rules EPA Case 'Commandeered' by Lower Court
Federal Appeals Court Rejects Federal Judge's Ruling as Beyond His Purview
*
The American Dental Association (ADA) applauds the recent U.S. Court of Appeals for the Ninth Circuit on their decision to overturn the lower court's 2024 order that had directed the Environmental Protection Agency (EPA) to regulate fluoride in drinking water under the Toxic Substances Control Act.
The appellate panel ruled that the district judge overstepped
... Show Full Article
CHICAGO, Illinois, May 23 -- The American Dental Association issued the following news release:
* * *
Court of Appeals Rules EPA Case 'Commandeered' by Lower Court
Federal Appeals Court Rejects Federal Judge's Ruling as Beyond His Purview
*
The American Dental Association (ADA) applauds the recent U.S. Court of Appeals for the Ninth Circuit on their decision to overturn the lower court's 2024 order that had directed the Environmental Protection Agency (EPA) to regulate fluoride in drinking water under the Toxic Substances Control Act.
The appellate panel ruled that the district judge oversteppedjudicial bounds and commandeered the case. The initial decision for the judge to include pending evidence on his own accord overstepped the process while waiting for the report that was not the evidence presented by either party in the lawsuit. The three-judge panel returns the case to the lower court requiring review with a narrower evidentiary record.
"The appellate court recognized and noted that the lower court improperly overstepped its role and relied on a pending report, presented by neither party in the case was an abuse of discretion," said Rich Rosato, D.M.D., president of the American Dental Association. "We strongly support the appeals court's decision and believe that the best scientific evidence for more than 80 years consistently has demonstrated that community water fluoridation is both safe and effective."
The ADA believes the recent court ruling could correct a fundamental misunderstanding and misapplication of the prevailing scientific literature on the safety of fluoride and community water fluoridation. The Association strongly supports the decision and its role in restoring clarity and confidence in long-established public health science.
"The lower court ruling relied in part on materials that were never presented to the EPA, making the decision to require additional review of fluoride standards unjustified," said Dr. Rosato. "We hope that the lower court takes the opportunity now to correct the record and provide reassurance to the American public, policymakers, and any doubters about the safety and value of community water fluoridation in the face of ongoing misinformation sparked by this previous court decision."
The American Dental Association filed an amicus brief (PDF) July 25, 2025, in support of the Environmental Protection Agency's appeal and is committed to work with the agency on reviewing the latest U.S. based analyses demonstrating how water at optimal levels does not impact IQ or cognitive function in adolescence through age 80.
The ADA will continue to be a staunch supporter of community water fluoridation at optimal levels to help prevent tooth decay. For more information on community water fluoridation, visit ADA.org/Fluoride.
* * *
About the American Dental Association
The not-for-profit ADA is the nation's largest dental association, representing 152,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance has long been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA), published monthly, is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org.
* * *
Original text here: https://www.ada.org/about/press-releases/court-of-appeals-rules-epa-case-commandeered-by-lower-court
[Category: Dentistry]
American College of Cardiology Issues Decision Pathway for Postpartum Cardiovascular Care
WASHINGTON, May 23 (TNSjou) -- The American College of Cardiology posted the following news release:
* * *
American College of Cardiology Issues Decision Pathway for Postpartum Cardiovascular Care
Clinical document provides key guidance for optimizing postpartum maternal cardiovascular health
*
A new Expert Consensus Decision Pathway by the American College of Cardiology (ACC) provides recommended strategies for improving postpartum care for individuals with and at risk for short- and long-term cardiovascular disease (CVD). The clinical document guides postpartum maternal cardiovascular (CV)
... Show Full Article
WASHINGTON, May 23 (TNSjou) -- The American College of Cardiology posted the following news release:
* * *
American College of Cardiology Issues Decision Pathway for Postpartum Cardiovascular Care
Clinical document provides key guidance for optimizing postpartum maternal cardiovascular health
*
A new Expert Consensus Decision Pathway by the American College of Cardiology (ACC) provides recommended strategies for improving postpartum care for individuals with and at risk for short- and long-term cardiovascular disease (CVD). The clinical document guides postpartum maternal cardiovascular (CV)health, recommending comprehensive postpartum cardiovascular care visits; early outpatient follow up for CV symptom monitoring; effective management of postpartum CV emergencies; and noncardiovascular aspects of care like lactation, mental health and contraception. The report published online today in JACC, the flagship journal of the ACC.
More than half of pregnancy-related deaths occur after the birth of an infant, and the risk of death rises substantially in the early postpartum period, especially the first two weeks postpartum. Individuals with the greatest risk include those with risk factors such as hypertension, obesity and dyslipidemia, as well as risk enhancers like gestational diabetes, hypertensive disorders of pregnancy and preterm birth.
"The postpartum period is a critical opportunity to engage in collaborative patient care that is focused on improving short- and long-term cardiometabolic outcomes," said Kathryn J. Lindley, MD, FACC, chair of the ECDP writing committee and associate professor of medicine at Vanderbilt University Medical Center's Division of Cardiovascular Medicine. "Understanding and following a structured approach to the provision of postpartum care for all individuals with or at risk for CVD is a crucial first step toward eliminating excess maternal morbidity and mortality and reducing inequities."
The clinical document acknowledges the many barriers to care during the postpartum period and emphasizes the importance of following a structured approach for optimized maternal CV health care that begins immediately after delivery and extends through the first year.
Recommended postpartum maternal CV health care includes early blood pressure management and CV symptom screening, comprehensive CV risk factor modification and effective transition to longitudinal preventative care before the end of the first year after delivery.
The document is a report (https://www.jacc.org/doi/10.1016/j.jacc.2025.11.001) of the American College of Cardiology Solution Set Oversight Committee and was developed in collaboration with and is endorsed by the American College of Nurse-Midwives, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine.
For an embargoed copy of the report "Optimization of Postpartum Care for Patients With and At Risk for Premature and Long-Term Cardiovascular Disease: 2026 ACC Expert Consensus Decision Pathway," contact JACC Media Relations Manager Olivia Walther at owalther@acc.org.
* * *
The American College of Cardiology (ACC) is a global leader dedicated to transforming cardiovascular care and improving heart health for all. For more than 75 years, the ACC has empowered a community of over 60,000 cardiovascular professionals across more than 140 countries with cutting-edge education and advocacy, rigorous professional credentials, and trusted clinical guidance. From its world-class JACC Journals and NCDR registries to its Accreditation Services, global network of Chapters and Sections, and CardioSmart patient initiatives, the College is committed to creating a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or connect on social media at @ACCinTouch.
* * *
The ACC's JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) -- and specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure -- pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.
* * *
Original text here: https://www.acc.org/About-ACC/Press-Releases/2026/05/22/16/53/American-College-of-Cardiology-Issues-Decision-Pathway-for-Postpartum-Cardiovascular-Care
[Category: Medical]
ALTA Reports 2025 Market Share and Title Insurance Premium Volume
WASHINGTON, May 23 -- The American Land Title Association issued the following news release:
* * *
ALTA Reports 2025 Market Share and Title Insurance Premium Volume
The American Land Title Association (ALTA), the national trade association of the land title insurance industry, announced that the title insurance industry generated $18.5 billion in title insurance premiums during 2025, according to ALTA's latest Market Share Analysis.
This represents a 13.8% increase compared to 2024.
"While the housing market continued to face affordability pressures and constrained inventory in 2025, the
... Show Full Article
WASHINGTON, May 23 -- The American Land Title Association issued the following news release:
* * *
ALTA Reports 2025 Market Share and Title Insurance Premium Volume
The American Land Title Association (ALTA), the national trade association of the land title insurance industry, announced that the title insurance industry generated $18.5 billion in title insurance premiums during 2025, according to ALTA's latest Market Share Analysis.
This represents a 13.8% increase compared to 2024.
"While the housing market continued to face affordability pressures and constrained inventory in 2025, theincrease in title insurance premium volume reflects the resilience of the real estate economy and the essential role title professionals play in every transaction," said ALTA CEO Chris Morton. "Every policy represents extensive research, risk mitigation and consumer protection work happening behind the scenes to help buyers, sellers and lenders close transactions with confidence. As fraud schemes become more sophisticated and transactions grow more complex, the expertise of title and settlement professionals has never been more important."
As mortgage originations increased in 2025, title insurance premium volume also grew.
The title industry closed out the year with a strong fourth quarter, as title premium volume increased 14.5% compared with the same period in 2024.
In 2025, the industry paid more than $667 million in claims. This is down from $676 million in claims paid in 2024.
Top 10 Individual Underwriters by 2025 Market Share
* First American Title Insurance Co., 23.1%
* Fidelity National Title Insurance Co., 14.5%
* Old Republic Title Insurance Co., 14.0%
* Chicago Title Insurance Co., 13.1%
* Stewart Title Insurance Co., 10.9%
* Westcor Land Title Insurance Co., 4.2%
* Title Resources Guaranty Co., 4.0%
* Commonwealth Land Title Insurance Co., 3.3%
* WFG National Title Insurance Co., 2.6%
* First American Title Guaranty Co., 1.5%
Top 5 States During 2025
* Texas: $2.7 billion, +14.1%
* Florida: $2.01 billion, +5.2%
* California: $1.6 billion, +10.1%
* New York: $1.2 billion, +27.3%
* Pennsylvania: $709 million, +11.0%
Click here (https://www.alta.org/business-operations/research-initiatives-and-resources/industry-financial-data/) for more market share data.
ALTA expects to release Q1 2026 market data around June 1.
* * *
About ALTA
The American Land Title Association, founded in 1907, represents an industry comprised of more than 17,000 title insurance companies operating across the nation, with over 90% being small businesses.
* * *
Original text here: https://www.alta.org/news-and-publications/press-release/ALTA-Reports-2025-Market-Share-and-Title-Insurance-Premium-Volume
[Category: Real Estate]
